These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
252 related items for PubMed ID: 16906320
1. The clinical impact of MTHFR polymorphism on the vascular complications of sickle cell disease. Moreira Neto F, Lourenço DM, Noguti MA, Morelli VM, Gil IC, Beltrão AC, Figueiredo MS. Braz J Med Biol Res; 2006 Oct; 39(10):1291-5. PubMed ID: 16906320 [Abstract] [Full Text] [Related]
2. Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India. Nishank SS, Singh MP, Yadav R. Eur J Haematol; 2013 Nov; 91(5):462-6. PubMed ID: 23992124 [Abstract] [Full Text] [Related]
3. MTHFR polymorphic variant C677T is associated to vascular complications in sickle-cell disease. Hatzlhofer BL, Bezerra MA, Santos MN, Albuquerque DM, Freitas EM, Costa FF, Araújo AS, Muniz MT. Genet Test Mol Biomarkers; 2012 Sep; 16(9):1038-43. PubMed ID: 22924497 [Abstract] [Full Text] [Related]
4. Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study. Mueller T, Marschon R, Dieplinger B, Haidinger D, Gegenhuber A, Poelz W, Webersinke G, Haltmayer M. J Vasc Surg; 2005 May; 41(5):808-15. PubMed ID: 15886665 [Abstract] [Full Text] [Related]
12. Thrombophilic Mutations Among Patients with Sickle Cell Disease. Nefissi RB, Ouali F, Massaoud T, Gritli N. Clin Lab; 2017 Nov 01; 63(11):1815-1818. PubMed ID: 29226645 [Abstract] [Full Text] [Related]
13. Thrombophilic mutations among Southern Iranian patients with sickle cell disease: high prevalence of factor V Leiden. Rahimi Z, Vaisi-Raygani A, Nagel RL, Muniz A. J Thromb Thrombolysis; 2008 Jun 01; 25(3):288-92. PubMed ID: 17619828 [Abstract] [Full Text] [Related]
14. -455G/A beta-fibrinogen gene polymorphism, factor V Leiden, prothrombin G20210A mutation and MTHFR C677T, and placental vascular complications. Camilleri RS, Peebles D, Portmann C, Everington T, Cohen H. Blood Coagul Fibrinolysis; 2004 Mar 01; 15(2):139-47. PubMed ID: 15091001 [Abstract] [Full Text] [Related]
15. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis. Almawi WY, Tamim H, Kreidy R, Timson G, Rahal E, Nabulsi M, Finan RR, Irani-Hakime N. J Thromb Thrombolysis; 2005 Jun 01; 19(3):189-96. PubMed ID: 16082606 [Abstract] [Full Text] [Related]
16. Factor V G1691A, prothrombin G20210A and methylenetetrahydrofolate reductase polymorphism C677T are not associated with coronary artery disease and type 2 diabetes mellitus in western Iran. Rahimi Z, Nomani H, Mozafari H, Vaisi-Raygani A, Madani H, Malek-Khosravi S, Parsian A. Blood Coagul Fibrinolysis; 2009 Jun 01; 20(4):252-6. PubMed ID: 19349859 [Abstract] [Full Text] [Related]
17. A C677T methylenetetrahydrofolate reductase (MTHFR) polymorphism and G20210A mutation in the prothrombin gene of sickle cell anemia patients from Northeast Brazil. Couto FD, Boas WV, Lyra I, Zanette A, Dupuit MF, Almeida MN, Reis MG, Gonçalves MS. Hemoglobin; 2004 Aug 01; 28(3):237-41. PubMed ID: 15481892 [Abstract] [Full Text] [Related]
18. MTHFR (C677T, A1298C), FV Leiden polymorphisms, and the prothrombin G20210A mutation in arterial ischemic stroke among young tunisian adults. M'barek L, Sakka S, Meghdiche F, Turki D, Maalla K, Dammak M, Kallel C, Mhiri C. Metab Brain Dis; 2021 Mar 01; 36(3):421-428. PubMed ID: 33400068 [Abstract] [Full Text] [Related]
19. The Prevalence of Factor V Leiden (G1691A) and Methylenetetrahydrofolate Reductase C677T Mutations in Sickle Cell Disease in Western India. Kangne HK, Jijina FF, Italia YM, Jain DL, Nadkarni AH, Ghosh KK, Colah RB. Clin Appl Thromb Hemost; 2015 Mar 01; 21(2):186-9. PubMed ID: 23869056 [Abstract] [Full Text] [Related]
20. Prevalence of thrombotic risk factors among beta-thalassemia patients from Western Iran. Rahimi Z, Ghaderi M, Nagel RL, Muniz A. J Thromb Thrombolysis; 2008 Dec 01; 26(3):229-33. PubMed ID: 17982733 [Abstract] [Full Text] [Related] Page: [Next] [New Search]